Clinical trials: Microcirculation Resistance
Coronary Artery Disease, Microcirculation Resistance
COronoary Microcirculation Analysis NETwork
COMA.NET (Coronary Microcirculation Analysis Network) is a prospective, randomized, open-label, parallel-group clinical trial designed to determine whether endotype-guided pharmacotherapy is superior to standard care in improving…
- Conditions
- Coronary Artery Disease, Microcirculation Resistance, Microcirculation; Biomarkers; Myocardial Ischemia, Microcirculatory Dysfunction
- Trial name
- COMA-NET (NCT07498231)
- Testing
- Coronary microvascular function assessment
- Where
- Poland
- Volunteers
- 180 people
- Sponsor
- Medical University of Bialystok
Coronary Artery Disease, Microcirculation
The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease
The study should enrol 50 patients with stable coronary artery disease scheduled for elective percutaneous coronary intervention of single, de novo lesion of native coronary artery.
- Conditions
- Coronary Artery Disease, Microcirculation, Vascular Resistance
- Trial name
- PATMOS (NCT02107144)
- Testing
- trimetazidine
- Where
- Serbia
- Volunteers
- 71 people
- Sponsor
- Clinical Hospital Center Zemun
Microvascular Dysfunction, Hypertrophic Obstructive Cardiomyopathy
Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy
About 60% of patients with hypertrophic cardiomyopathy have microvascular dysfunction. Microvascular dysfunction is directly related to prognosis in hypertrophic cardiomyopathy.
- Conditions
- Microvascular Dysfunction, Hypertrophic Obstructive Cardiomyopathy, Microcirculation Resistance
- Trial name
- NCT05671367
- Where
- China
- Volunteers
- 340 people
- Sponsor
- China National Center for Cardiovascular Diseases
Breast Neoplasms, Exercise
Adapted Physical Activity (APA) in a Breast Cancer Population.
The aim of this study is to investigate the effect of a 6-months program of Adapted Physical Activity (APA) on lifestyle, physical activity levels, insulin resistance and adipokines, oxidative stress, microcirculatory…
- Conditions
- Breast Neoplasms, Exercise, Exercise Therapy, Insulin Resistance
- Trial name
- NCT03528473
- Testing
- Exercise
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University Of Perugia
Hypertension, Insulin Resistance
Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1.
- Conditions
- Hypertension, Insulin Resistance, Microcirculation
- Trial name
- NCT00742066
- Testing
- Irbesartan, Felodipine
- Where
- Netherlands
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Maastricht University Medical Center
Insulin Sensitivity, Microcirculation
Role of Angiotensin II in Insulin-induced Microvascular Activity
In this study we hypothesize infusion of Angiotensin II improves the insulin-induced microvascular dilatation and therefore insulin-mediated glucose uptake.
- Trial name
- NCT01024543
- Testing
- Angiotensin II, Phenylephrine
- Where
- Netherlands
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- Maastricht University Medical Center